Bayram Ali, Doğan Murat, Koç Ali, Kalkan Mehmet, Akçadağ Alper, Özcan İbrahim
Department of ENT, Kayseri Training and Research Hospital, Kayseri, Turkey.
Department of ENT, Kayseri Training and Research Hospital, Kayseri, Turkey.
Am J Otolaryngol. 2015 Jul-Aug;36(4):503-8. doi: 10.1016/j.amjoto.2015.03.004. Epub 2015 Apr 7.
To investigate vestibular evoked myogenic potentials combined with audiologic status in Behcet's disease (BD) and to compare the results with normal healthy subjects.
Cervical vestibular evoked myogenic potential (cVEMP) test, ocular vestibular evoked myogenic potential (oVEMP) test, Dix-Hallpike test, conventional pure tone audiometry (cPTA) and high frequency audiometry (HFA), and 226 and 1000Hz tympanometry were performed to each subject of the study. Cranial magnetic resonance imaging (MRI) with contrast enhancement was also performed to evaluate the central nervous system (CNS) in patients with BD.
VEMP parameters including the mean peak latencies of p13-n23 and n10-p15, AR values and thresholds were not statistically different both in cVEMP and oVEMP between the BD and control groups. Except for 250Hz, mean audiological thresholds were significantly higher in the BD group. Five of the 20 patients had pathological cranial MRI findings that may be compatible with central nervous system involvement.
To our knowledge, the present study is the first report investigating oVEMP and cVEMP responses combined with MRI findings in patients with BD. The presence of high frequency hearing loss is a common finding in BD and HFA may help early detection of hearing loss in patients with BD when combined with cPTA.
研究白塞病(BD)患者的前庭诱发肌源性电位并结合听力学状况,与正常健康受试者的结果进行比较。
对本研究的每位受试者进行颈前庭诱发肌源性电位(cVEMP)测试、眼前庭诱发肌源性电位(oVEMP)测试、Dix-Hallpike试验、常规纯音听力测定(cPTA)和高频听力测定(HFA),以及226和1000Hz鼓室导抗测试。还对BD患者进行了增强对比的头颅磁共振成像(MRI)以评估中枢神经系统(CNS)。
BD组和对照组在cVEMP和oVEMP中,包括p13-n23和n10-p15的平均峰潜伏期、AR值和阈值在内的VEMP参数在统计学上无差异。除250Hz外,BD组的平均听阈显著更高。20例患者中有5例头颅MRI检查结果异常,可能与中枢神经系统受累有关。
据我们所知,本研究是首次报道在BD患者中研究oVEMP和cVEMP反应并结合MRI检查结果。高频听力损失在BD中是常见表现,HFA与cPTA联合应用可能有助于早期发现BD患者的听力损失。